VANNA ALTMAN: Open Payments
NPI 1669576922 · WINCHESTER, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,395 in 172 payments from 18 companies in 2025. Trend: 2023 $4,234 · 2024 $5,897 · 2025 $4,395
Food & beverage: $4,232Education: $163
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 23 | $904 |
| Galderma Laboratories, L.P. | 29 | $627 |
| UCB, Inc. | 17 | $525 |
| Arcutis Biotherapeutics, Inc. | 10 | $454 |
| Incyte Corporation | 12 | $240 |
| ABBVIE INC. | 22 | $226 |
| Regeneron Healthcare Solutions, Inc. | 11 | $207 |
| LEO Pharma Inc. | 3 | $162 |
| Lilly USA, LLC | 8 | $151 |
| Novartis Pharmaceuticals Corporation | 6 | $143 |
Products named: TREMFYA, NEMLUVIO, Bimzelx, DUPIXENT, Zoryve, OPZELURA, SKYRIZI, ANZUPGO.
Industry payments across MA — which companies pay providers there.
